17-Jan-2025
No headlines found.
CareCloud Announces 94% Shareholder Support for Proposal to Increase Authorized Shares
Globe Newswire (Mon, 6-Jan 8:00 AM ET)
CareCloud Announces Leadership Realignment to Drive 2025 Growth Strategy
Globe Newswire (Mon, 16-Dec 8:05 AM ET)
CareCloud Files Special Meeting Proxy to Accelerate Growth
Globe Newswire (Mon, 9-Dec 8:10 AM ET)
PRNewswire (Thu, 21-Nov 9:48 AM ET)
CareCloud Reports Third Quarter 2024 Results
Globe Newswire (Tue, 12-Nov 7:00 AM ET)
CareCloud Pays Off Credit Line, Signs an Updated Credit Facility Agreement
Globe Newswire (Mon, 28-Oct 8:00 AM ET)
CareCloud To Announce Third Quarter 2024 Results on November 12, 2024
Globe Newswire (Thu, 24-Oct 8:00 AM ET)
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
Carecloud trades on the NASDAQ stock market under the symbol CCLD.
As of January 17, 2025, CCLD stock price climbed to $2.79 with 81,457 million shares trading.
CCLD has a market cap of $45.35 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that CCLD belongs to (by Net Assets): VTI, VXF, BSVO, DCOR, DFSU.
CCLD has outperformed the market in the last year with a return of +95.1%, while the SPY ETF gained +28.0%. In the last 3 month period, CCLD beat the market returning +6.1%, while SPY returned +3.0%. However, in the most recent 2 weeks CCLD has underperformed the stock market by returning -24.0%, while SPY returned +1.0%.
CCLD support price is $2.47 and resistance is $2.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCLD shares will trade within this expected range on the day.